These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1737752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adenine nucleotide binding and photoincorporation in Glanzmann's thrombasthenia platelets.
    Greco NJ, Tandon NN, Jackson B, Jamieson GA.
    Biochim Biophys Acta; 1995 May 24; 1236(1):142-8. PubMed ID: 7794942
    [Abstract] [Full Text] [Related]

  • 5. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D.
    Thromb Res; 2013 Nov 24; 132(5):548-57. PubMed ID: 24071464
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.
    Cooper CL, Morris AJ, Harden TK.
    J Biol Chem; 1989 Apr 15; 264(11):6202-6. PubMed ID: 2495280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS, Hourani SM.
    Br J Pharmacol; 1999 Jul 15; 127(6):1359-66. PubMed ID: 10455285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding.
    Figures WR, Scearce LM, Wachtfogel Y, Chen J, Colman RF, Colman RW.
    J Biol Chem; 1986 May 05; 261(13):5981-6. PubMed ID: 3009439
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1991 May 01; 286(2):419-27. PubMed ID: 1910292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN, Colman RW.
    J Cell Biochem; 1996 Apr 01; 61(1):97-108. PubMed ID: 8726359
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.